
Biogen BIIB
$ 187.88
-1.08%
Annual report 2025
added 02-06-2026
Biogen P/B Ratio 2011-2026 | BIIB
Annual P/B Ratio Biogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.61 | 1.16 | 1.3 | 3.02 | 2.87 | 4.11 | 3.89 | 5.16 | 5.95 | 4.97 | 6.72 | 8.51 | 8.75 | 5.3 | 4.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.75 | 1.16 | 4.51 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | ||
|
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | ||
|
ADMA Biologics
ADMA
|
7.92 | $ 15.57 | -5.89 % | $ 3.71 B | ||
|
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | ||
|
AbCellera Biologics
ABCL
|
0.995 | $ 3.58 | -1.38 % | $ 1.07 B | ||
|
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Anika Therapeutics
ANIK
|
1.38 | $ 14.19 | -1.18 % | $ 208 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | ||
|
Aptorum Group Limited
APM
|
0.347 | $ 0.82 | -0.73 % | $ 4.47 M | ||
|
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | ||
|
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | ||
|
Apellis Pharmaceuticals
APLS
|
7.49 | $ 20.24 | 1.91 % | $ 2.55 B | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | ||
|
ANI Pharmaceuticals
ANIP
|
2.79 | $ 75.6 | -1.22 % | $ 1.46 B | ||
|
Applied Therapeutics
APLT
|
-31.5 | - | - | $ 8.42 M | ||
|
Autolus Therapeutics plc
AUTL
|
0.991 | $ 1.5 | -8.28 % | $ 383 M | ||
|
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | ||
|
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
Athersys
ATHX
|
11.6 | - | 3.77 % | $ 22.4 M | ||
|
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | ||
|
AVEO Pharmaceuticals
AVEO
|
2.14 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
98.2 | $ 159.87 | -2.57 % | $ 7.95 B | ||
|
BridgeBio Pharma
BBIO
|
-6.31 | $ 65.73 | -1.22 % | $ 12.6 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.815 | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
1.64 | - | -4.8 % | $ 255 M | ||
|
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
0.415 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
0.824 | - | -7.31 % | $ 87 M | ||
|
Equillium
EQ
|
3.75 | $ 1.79 | 2.29 % | $ 62.2 M | ||
|
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | ||
|
Bellerophon Therapeutics
BLPH
|
31 | - | -74.18 % | $ 955 K | ||
|
BioLineRx Ltd.
BLRX
|
19.9 | $ 2.72 | -3.31 % | $ 908 M | ||
|
BioMarin Pharmaceutical
BMRN
|
1.92 | $ 60.54 | 0.18 % | $ 11.6 B | ||
|
Burford Capital Limited
BUR
|
1.26 | $ 8.26 | -1.31 % | $ 1.36 B | ||
|
Cabaletta Bio
CABA
|
0.0867 | $ 3.2 | -6.71 % | $ 3.74 M | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
0.000684 | $ 2.93 | -8.44 % | $ 1.05 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | ||
|
Capricor Therapeutics
CAPR
|
6.87 | $ 25.74 | 0.94 % | $ 689 M |